Cadre Holdings, Inc. (CDRE) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Cadre Holdings, Inc. (CDRE) stock forecast summary
On Oct. 16, 2026, CDRE is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5171 stocks scored that day.
Cadre Holdings, Inc. is a small-cap company with a market capitalization of $1.13B. It ranks number 9 by market capitalization among the 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For CDRE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 7.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CDRE included.
Follow CDRE freeCDRE price chart and AI forecast
How CDRE ranks among 5171 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cadre Holdings, Inc. (CDRE) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Valuation & Market
| Metric | CDRE | Rank |
|---|---|---|
| Market Cap | $1.13B | 9/27 |
| P/E Ratio | 26.92x | 3/9 |
| P/B Ratio | 3.26x | 8/22 |
| Dividend Yield | 1.44% | – |
| EPS | $0.98 | – |
| Book Value/Share | $8.10 | – |
| Revenue/Share | $16.01 | – |
| FCF/Share | $1.82 | – |
Profitability & Margins
| Metric | CDRE | Rank |
|---|---|---|
| ROE | 10.4% | 4/19 |
| ROA | 3.9% | 6/19 |
| ROIC | 9.2% | 8/22 |
| Gross Margin | 41.8% | 13/20 |
| Operating Margin | 10.1% | 7/21 |
| Net Margin | 5.3% | 7/17 |
| EBT Margin | 7.6% | 6/21 |
| Tax Rate | 31.0% | – |
Financial Health
| Metric | CDRE | Rank |
|---|---|---|
| Current Ratio | 2.14x | 17/25 |
| Quick Ratio | 1.35x | 14/22 |
| D/E Ratio | 1.65x | 5/24 |
| Financial Leverage | 2.65x | 5/24 |
| Interest Coverage | 4.3x | 4/21 |
| Working Capital | $186M | 9/25 |
Cash Flow
| Metric | CDRE | Rank |
|---|---|---|
| Operating Cash Flow | $88M | 8/25 |
| Free Cash Flow | $78M | 5/16 |
| Capital Spending | -$10M | 11/16 |
| OCF Growth YoY | 129.7% | 1/10 |
| FCF Growth YoY | 133.6% | 3/7 |
| FCF/Sales | 11.4% | 5/16 |
| CapEx/Sales | 1.5% | 8/16 |
Operational Efficiency
| Metric | CDRE | Rank |
|---|---|---|
| Asset Turnover | 0.75x | 7/18 |
| Receivables Turnover | 5.3x | 10/17 |
| Inventory Turnover | 3.1x | 9/22 |
| Fixed Assets Turnover | 5.5x | 10/19 |
| Days Sales Outstanding | 68 days | 8/17 |
| Days Inventory | 118 days | 14/22 |
| Payables Period | 36 days | 16/19 |
| Cash Conversion Cycle | 151 days | 6/15 |
Income Statement
| Metric | CDRE | Rank |
|---|---|---|
| Total Revenue | $686M | 6/19 |
| Operating Income | $69M | 7/25 |
| Net Income | $36M | 6/19 |
| SG&A Expense | $208M | 9/22 |
| Cost of Goods Sold | $399M | 8/22 |
Dividend & Shareholder Information
| Metric | CDRE | Rank |
|---|---|---|
| Dividends Per Share | $0.38 | – |
| Payout Ratio | 38.8% | – |
| Shares Outstanding | 43M | – |
| Net Income Growth | -5.3% | 6/7 |
| EPS Growth | 10.1% | 6/8 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $348M | 38.0% of assets |
| Cash & Short-term Investments | $54M | 5.9% of assets |
| Accounts Receivable | $128M | 14.0% of assets |
| Inventory | $129M | 14.1% of assets |
| Total Liabilities | $570M | 62.2% of assets |
| Short-term Debt | $124M | 13.5% of assets |
CDRE quarterly financials and insider trading
Cadre Holdings, Inc. (CDRE) industry peers
Companies classified under the same SEC industry code as Cadre Holdings, Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| CDRE Cadre Holdings, Inc. | ▶ | $1.13B |
| ISRG Intuitive Surgical Inc | ▼ | $150.74B |
| STE Steris Plc | ▼ | $21.71B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $18.12B |
| SNN Smith & Nephew Plc | ▼ | $12.75B |
| ALGN Align Technology Inc | ▶ | $10.46B |
| MSA Msa Safety Inc | ▼ | $6.91B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.76B |
| ENOV Enovis Corp | ▶ | $1.13B |
| AVR Anteris Technologies Global Corp. | ▶ | $590M |
| SMTI Sanara Medtech Inc. | ▼ | $305M |
| INGN Inogen Inc | ▶ | $166M |
| LAKE Lakeland Industries Inc | ▲ | $90M |
| NTRB Nutriband Inc. | ▲ | $76M |
| APT Alpha Pro Tech Ltd | ▶ | $57M |
| COCH Envoy Medical, Inc. | ▶ | $50M |
| MYO Myomo, Inc. | ▲ | $48M |
| MLSS Milestone Scientific Inc. | ▲ | $29M |
| LFWD Lifeward Ltd. | ▲ | $17M |
| CUPR Cuprina Holdings (Cayman) Ltd | ▶ | $14M |
| UEEC United Health Products, Inc. | ▲ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▲ | $11M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $7M |
| LGMK Logicmark, Inc. | ▲ | $1M |
| BBLG Bone Biologics Corp | ▲ | $1M |
| RBOT Vicarious Surgical Inc. | ▲ | $550K |
| FEED Envue Medical, Inc. | ▼ | $450K |
Where CDRE sits on the market map
Cadre Holdings, Inc. (CDRE) stock news
Loading...
Cadre Holdings, Inc. (CDRE) stock forecast FAQ
What is the Cadre Holdings, Inc. (CDRE) stock forecast?
On Oct. 16, 2026, CDRE is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5171 stocks scored that day.
How accurate are Cadre Holdings, Inc. stock predictions?
For CDRE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 7.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cadre Holdings, Inc. forecasts updated?
Cadre Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Cadre Holdings, Inc.'s industry peers?
27 issuers in our coverage, CDRE included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.